Trialists perspectives on sustaining, spreading, and scaling-up of quality improvement interventions

被引:7
|
作者
Laur, Celia [1 ,2 ]
Corrado, Ann Marie [3 ]
Grimshaw, Jeremy M. [4 ,5 ]
Ivers, Noah [1 ,2 ,6 ,7 ]
机构
[1] Womens Coll Hosp, Inst Hlth Syst Solut & Virtual Care, 76 Grenville St, Toronto, ON, Canada
[2] Womens Coll Hosp, Womens Coll, Res Inst, 76 Grenville St, Toronto, ON, Canada
[3] Womens Coll Hosp, Peter Gilgan Ctr Womens Canc, Toronto, ON, Canada
[4] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada
[5] Univ Ottawa, Dept Med, Ottawa, ON, Canada
[6] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada
[7] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
来源
基金
加拿大健康研究院;
关键词
Sustainability; Spread; Scale; Implementation; Learning health systems; Knowledge translation; Quality improvement; Diabetes; HEALTH SYSTEM; SUSTAINABILITY; MANAGEMENT;
D O I
10.1186/s43058-021-00137-6
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Quality improvement (QI) evaluations rarely consider how a successful intervention can be sustained long term, nor how to spread or scale to other locations. A survey of authors of randomized trials of diabetes QI interventions included in an ongoing systematic review found that 78% of trials reported improved quality of care, but 40% of these trials were not sustained. This study explores why and how the effective interventions were sustained, spread, or scaled.Methods A qualitative approach was used, focusing on case examples. Diabetes QI program trial authors were purposefully sampled and recruited for telephone interviews. Authors were eligible if they had completed the author survey, agreed to follow-up, and had a completed a diabetes QI trial they deemed "effective." Snowball sampling was used if the participant identified someone who could provide a different perspective on the same trial. Interviews were transcribed verbatim. Inductive thematic analysis was conducted to identify barriers and facilitators to sustainability, spread, and/or scale of the QI program, using case examples to show trajectories across projects and people.Results Eleven of 44 eligible trialists participated in an interview. Four reported that the intervention was "sustained" and nine were "spread," however, interviews highlighted that these terms were interpreted differently over time and between participants. Participant stories highlighted the varied trajectories of how projects evolved and how some research careers adapted to increase impact. Three interacting themes, termed the "3C's," helped explain the variation in sustainability, spread, and scale: (i) understanding the concepts of implementation, sustainability, sustainment, spread, and scale; (ii) having the appropriate competencies; and (iii) the need for individual, organizational, and system capacity.Conclusions Challenges in defining sustainability, spread and scale make it difficult to fully understand impact. However, it is clear that from the beginning of intervention design, trialists need to understand the concepts and have the competency and capacity to plan for feasible and sustainable interventions that have potential to be sustained, spread and/or scaled if found to be effective.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Implementer and researcher perspectives on sustaining, spreading and scaling up, quality improvement interventions
    Laur, Celia
    Corrado, Ann Marie
    Grimshaw, Jeremy
    Ivers, Noah
    [J]. IMPLEMENTATION SCIENCE, 2020, 15 (SUPPL 4):
  • [2] Accounting for the cost of scaling-up health interventions
    Johns, B
    Baltussen, R
    [J]. HEALTH ECONOMICS, 2004, 13 (11) : 1117 - 1124
  • [3] The challenges of scaling-up and sustaining professional development school partnerships
    Breault, Donna Adair
    [J]. TEACHING AND TEACHER EDUCATION, 2013, 36 : 92 - 100
  • [4] Scaling-up metabolomics: Current state and perspectives
    Hajjar, Ghina
    Santos, Millena C. Barros
    Bertrand-Michel, Justine
    Castelli, Florence
    Creusot, Nicolas
    Dechaumet, Sylvain
    Dieme, Binta
    Giacomoni, Franck
    Giraudeau, Patrick
    Guitton, Yann
    Thevenot, Etienne
    Tremblay-Franco, Marie
    Junot, Christophe
    Jourdan, Fabien
    Fenaille, Francois
    Comte, Blandine
    Petriacq, Pierre
    Pujos-Guillot, Estelle
    [J]. TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2023, 167
  • [5] Scaling-up and sustaining insecticide-treated net coverage
    Lines, J
    Lengeler, C
    Cham, K
    de Savigny, D
    Chimumbwa, J
    Langi, P
    Carroll, D
    Mills, A
    Hanson, K
    Webster, J
    Lynch, M
    Addington, W
    Hill, J
    Rowland, M
    Worrall, E
    MacDonald, M
    Kilian, A
    [J]. LANCET INFECTIOUS DISEASES, 2003, 3 (08): : 465 - 466
  • [6] Spreading and scaling up innovation and improvement
    Greenhalgh, Trisha
    Papoutsi, Chrysanthi
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2019, 365
  • [7] Scaling-up: Building, Leading and Sustaining Rapid Growth Over Time
    Jansen, Justin J. P.
    Heavey, Ciaran
    Mom, Tom J. M.
    Simsek, Zeki
    Zahra, Shaker A.
    [J]. JOURNAL OF MANAGEMENT STUDIES, 2023, 60 (03) : 581 - 604
  • [8] Scaling-up PEM Electrolysis Production: Challenges and Perspectives
    Locci, Carlo
    Mertens, Mara
    Hoeyng, Stefan
    Schmid, Guenter
    Bagus, Thomas
    Lettenmeier, Philipp
    [J]. CHEMIE INGENIEUR TECHNIK, 2024, 96 (1-2) : 22 - 29
  • [9] Improvement, scaling-up, and downstream analysis of exosome production
    Jafari, Davod
    Malih, Sara
    Eini, Maryam
    Jafari, Rasool
    Gholipourmalekabadi, Mazaher
    Sadeghizadeh, Majid
    Samadikuchaksaraei, Ali
    [J]. CRITICAL REVIEWS IN BIOTECHNOLOGY, 2020, 40 (08) : 1098 - 1112
  • [10] Changing cost of HIV interventions in the context of scaling-up in India
    Dandona, Lalit
    Kumar, S. G. Prem
    Ramesh, Y. K.
    Rao, M. Chalapathi
    Kumar, A. Anod
    Marseille, Elliot
    Kahn, James G.
    Dandona, Rakhi
    [J]. AIDS, 2008, 22 : S43 - S49